Sign up
Log in
Trading ideas: Duopharma, DNeX, Dayang, Varia, Kee Ming
Share
Listen to the news

KUALA LUMPUR: Duopharma Biotech Bhd, Dagang NeXchange Bhd (DNeX), Dayang Enterprise Holdings Bhd, Varia Bhd and Kee Ming Holdings Bhd are among the stocks to watch today following their latest news.

Duopharma has secured a three-year RM155.3mil contract from the Health Ministry to supply recombinant human insulin products and reusable insulin pens to government healthcare facilities nationwide, providing a positive earnings contribution through June 2029.

DNeX has acquired a 20% stake in TI Exploration & Production Sdn Bhd to strengthen its energy portfolio and expand its presence in Terengganu and the regional energy sector.

Dayang has entered into a 50:50 joint venture with Brunei-based Petrokon Utama Sdn Bhd (PUSB) to pursue maintenance, turnaround and construction opportunities in Brunei's oil and gas sector, supporting its strategy to expand its regional footprint and strengthen its presence in the country's energy industry.

Varia, through its indirect wholly owned subsidiary Varia Southrise Sdn Bhd, has partnered Seri Alam Properties Sdn Bhd to develop a RM250mil medium-cost residential project in Bandar Seri Alam, Johor Bahru, comprising 645 apartment units across two high-rise blocks.

Kee Ming has secured a RM21.36mil subcontract to undertake electrical engineering works for a hyperscale data centre project in Puncak Alam, boosting its order book and earnings visibility through end-2026.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.